Roivant Sciences Ltd. 8-K Report: Key Updates for Investors on February 19, 2025
From the extracted section of the financial report, here are the key pieces of information:
- Filing Type: The report is an 8-K, which is a current report used to disclose important events that shareholders should know about.
- Company Information:
- Name: Roivant Sciences Ltd.
- CIK Number: 0001635088
- Entity Identifier: D0 001-40782
- Tax Identification Number: 98-1173944
- Address: 7th Floor, 50 Broadway, London SW1H 0DB, GB
- Contact Number: 207 400-3347
- Common Shares:
- Par Value: $0.0000000341740141 per share
- Ticker Symbol: ROIV
- Exchange: NASDAQ
- Reporting Period:
- Date of Filing: February 19, 2025
- Reporting Period: The report covers a single day, February 19, 2025.
- XML and XBRL Context: The document is formatted in XBRL (eXtensible Business Reporting Language), which is commonly used for financial reporting to improve the accessibility and usability of financial data.
Insights:
- The 8-K filing suggests that Roivant Sciences Ltd. may have had a significant event or development on February 19, 2025, that warranted immediate disclosure to investors.
- The company is listed on NASDAQ under the ticker ROIV, indicating that it is a publicly traded entity.
- The extremely low par value of the common shares may suggest a high volume of shares outstanding or a strategic pricing decision by the company.
This information is crucial for investors and analysts who are tracking the company's performance and any pertinent changes within the organization.